Rankings
▼
Calendar
XOMAP FY 2024 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena
XOMAP
XOMA Corporation
$311M
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$28M
+498.7% YoY
Gross Profit
$28M
99.3% margin
Operating Income
-$40M
-140.3% margin
Net Income
-$14M
-48.5% margin
EPS (Diluted)
$-1.65
Cash Flow
Operating Cash Flow
-$14M
Free Cash Flow
-$14M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$221M
Total Liabilities
$139M
Stockholders' Equity
$82M
Cash & Equivalents
$102M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$28M
$5M
+498.7%
Gross Profit
$28M
$5M
+512.8%
Operating Income
-$40M
-$42M
+4.5%
Net Income
-$14M
-$41M
+66.2%
← Q4 2023
All Quarters
Q1 2024 →